Teams from Seven Countries Recognized with Achievement.
- Published in:
- Clinical Laboratory News, 2022, v. 48, n. 9, p. 1
- By:
- Publication type:
- Article
Works matching IS 01619640 AND DT 2022 AND VI 48 AND IP 9
Results: 23
1
2
Improving Utilization of Paraneoplastic Antibody Panels.
- Published in:
- Clinical Laboratory News, 2022, v. 48, n. 9, p. 36
- By:
- Publication type:
- Article
3
PRELUDEDX AND GALAXY HEALTH NETWORK AGREEMENT FOCUSES ON NOVEL DUCTAL CARCINOMA IN SITU TEST.
- Published in:
- Clinical Laboratory News, 2022, v. 48, n. 9, p. 35
- Publication type:
- Article
4
ILLUMINA TO APPEAL EUROPEAN COMMISSION'S DECISION ON GRAIL DEAL.
- Published in:
- Clinical Laboratory News, 2022, v. 48, n. 9, p. 34
- Publication type:
- Article
5
Sense and TECOmedical Sign European Distribution Agreement.
- Published in:
- Clinical Laboratory News, 2022, v. 48, n. 9, p. 34
- Publication type:
- Article
6
GENOMENON INTEGRATES CLINVAR DATA INTO ITS SEARCH ENGINE.
- Published in:
- Clinical Laboratory News, 2022, v. 48, n. 9, p. 35
- Publication type:
- Article
7
MYRIAD GENETICS’ BRACANALYSIS DIAGNOSTIC SYSTEM GAINS JAPANESE APPROVAL AS COMPANION DIAGNOSTIC.
- Published in:
- Clinical Laboratory News, 2022, v. 48, n. 9, p. 33
- Publication type:
- Article
8
LABCORP ACQUIRES NEW JERSEY OUTREACH LAB BUSINESS.
- Published in:
- Clinical Laboratory News, 2022, v. 48, n. 9, p. 34
- Publication type:
- Article
9
COLON CANCER ASSAY GETS CHINESE APPROVAL.
- Published in:
- Clinical Laboratory News, 2022, v. 48, n. 9, p. 33
- Publication type:
- Article
10
CE MARK GRANTED TO SKYLINEDX SKIN CANCER TEST.
- Published in:
- Clinical Laboratory News, 2022, v. 48, n. 9, p. 33
- Publication type:
- Article
11
HELIX DIAGNOSTICS’ MULTIPLEXED SARS-COV-2 ASSAY EARNS FDA EUA.
- Published in:
- Clinical Laboratory News, 2022, v. 48, n. 9, p. 30
- Publication type:
- Article
12
THERMO FISHER SCIENTIFIC GETS CE MARK FOR CANCER SEQUENCING TEST AND ANALYSIS SOFTWARE.
- Published in:
- Clinical Laboratory News, 2022, v. 48, n. 9, p. 30
- Publication type:
- Article
13
Early Cervical Cancer Test Approved in China.
- Published in:
- Clinical Laboratory News, 2022, v. 48, n. 9, p. 30
- Publication type:
- Article
14
Comparing Analytical Performance of High-Sensitivity Troponin Assays.
- Published in:
- Clinical Laboratory News, 2022, v. 48, n. 9, p. 24
- By:
- Publication type:
- Article
15
Implementing HIGH-SENSITIVITY CARDIAC TROPONIN.
- Published in:
- Clinical Laboratory News, 2022, v. 48, n. 9, p. 16
- By:
- Publication type:
- Article
16
Is Monkeypox Here to Stay?
- Published in:
- Clinical Laboratory News, 2022, v. 48, n. 9, p. 10
- By:
- Publication type:
- Article
17
BIOMARKERS PREDICT TBI OUTCOMES.
- Published in:
- Clinical Laboratory News, 2022, v. 48, n. 9, p. 9
- Publication type:
- Article
18
ALBUMINURIA LEVELS USEFUL FOR MANAGING NEWLY DIAGNOSED KIDNEY DISEASE.
- Published in:
- Clinical Laboratory News, 2022, v. 48, n. 9, p. 9
- Publication type:
- Article
19
New Risk Score Helps Show Who Needs Statins.
- Published in:
- Clinical Laboratory News, 2022, v. 48, n. 9, p. 8
- Publication type:
- Article
20
The Skinny on Lipid Reporting.
- Published in:
- Clinical Laboratory News, 2022, v. 48, n. 9, p. 4
- By:
- Publication type:
- Article
21
CMS TO CREATE NATIONAL HEALTHCARE DIRECTORY.
- Published in:
- Clinical Laboratory News, 2022, v. 48, n. 9, p. 2
- Publication type:
- Article
22
NATIONAL BIODEFENSE STRATEGY HIGHLIGHTS DIAGNOSTICS.
- Published in:
- Clinical Laboratory News, 2022, v. 48, n. 9, p. 2
- Publication type:
- Article
23
FDA Must Improve EUA Process, Federal Investigators Say.
- Published in:
- Clinical Laboratory News, 2022, v. 48, n. 9, p. 2
- Publication type:
- Article